Kuwani waa walaacyada udub-dhexaadka u ah mawduucyada qeexaya qolka-wareerka ee muhiimka u ah dhaqaalaha adduunka.
E-mailladayadu waxay ku iftiiminayaan sanduuqaaga, waxaana jira wax cusub subax kasta, galab kasta, iyo usbuuca dhammaadka.
Pratap Chandra, oo degan Lucknow, Uttar Pradesh, ayaa laga tijaabiyay difaaca jirka ee ka hortagga Covid 28 maalmood ka dib markii lagu duray Covishield.Ka dib markii baaritaanku ku soo gabagabeeyay inuusan lahayn wax ka hortag ah caabuqa fayraska, wuxuu soo gabagabeeyay in soo saaraha tallaalka iyo Wasaaradda Caafimaadka Hindiya ay tahay in la eedeeyo.
Covishield waa tallaalka AstraZeneca oo ay soo saarto machadka Serological Institute of India waana tallaalka ugu weyn ee barnaamijka tallaalka ee dalka ka socda.Ilaa hadda, inta badan 216ka milyan ee qiyaasood ee lagu duray Hindiya waa Covishield.
Habka sharciga weli lama go'aamin, laakiin cabashada Chandra lafteeda ayaa laga yaabaa inay ku salaysan tahay caddayn saynis ah oo aan degganayn.Khubarada ayaa sheegaya in baaritaanka kahortaga jirka uusan kuu sheegin in tallaalku waxtar leeyahay iyo in kale.
Dhinac, baadhista ka hortagga unugyadu waxay ogaan kartaa inaad hore u qaaday cudurkan sababtoo ah nooca difaaca jirka ee ay tijaabiso.Dhanka kale, tallaaladu waxay keenaan noocyo kala duwan oo unugyada difaaca jirka ah, kuwaas oo aan lagu ogaan karin baaritaannada degdega ah.
"Tallaalka ka dib, dad badan ayaa laga baari doonaa unugyada difaaca jirka -'Oh, waxaan rabaa in aan arko haddii ay shaqeyso.'Dhab ahaantii waa wax aan khusayn, "Luo Luo, agaasimaha fulinta ee machadka caafimaadka caalamiga ah iyo borofisar ku takhasusay caafimaadka iyo injineernimada noolaha ee Jaamacadda Waqooyi-galbeed.Ber Murphy ayaa u sheegay Washington Post bishii Febraayo."Dad badan ayaa leh natiijooyinka baaritaanka antibody-ka xun, taas macnaheedu maaha in tallaalku shaqeynayo," ayuu raaciyay.
Sababtan awgeed, Xarumaha Xakamaynta iyo Kahortagga Cudurrada (CDC) waxay ku talinayaan inaan la isticmaalin tijaabooyinka kahortagga kahortagga tallaalka ka dib, sababtoo ah baaritaannadaas ee tijaabiya unugyada difaaca jirka ee gaarka ah iyo baaritaannada la xiriira waxay aqoonsan karaan jawaabaha difaaca tallaalka.Tusaale ahaan, marka loo eego CDC, baaritaannadani ma aqoonsan karaan jawaabaha gacanta ee kakan, kuwaas oo door ka qaadan kara difaaca uu tallaalku keeno.
"Haddii natiijada baaritaanka antibody-ku ay xun tahay, qofka tallaalka qaadanaya waa inuusan argagixin ama walwalin, sababtoo ah baaritaanku kama ogaan karo unugyada difaacayaasha ee Pfizer, Moderna, iyo Johnson & Johnson's Janssen COVID-19, kuwaas oo laga soo saaray borotiinka sare.Fayruuska., "Fernando Martinez, oo ah agaasimaha daawada shaybaadhka ee MD Anderson Cancer Center ee Texas.Tallaalada sida Covishield sidoo kale waxay isticmaalaan borotiinnada sare ee coronavirus ee ku qoran DNA-ga adenovirus si ay u toosiyaan unugyada si ay u soo saaraan unugyada gaarka ah ee ka hortagga cudurka.
Waqtiga boostada: Juun-21-2021